SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-040172
Filing Date
2019-07-12
Accepted
2019-07-12 16:06:07
Documents
2
Period of Report
2019-07-10

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1599
2 EX-24 ex-24.htm EX-24 9722
  Complete submission text file 0001104659-19-040172.txt   12709
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 01776
Business Address
DeSchuytner Brian (Reporting) CIK: 0001782163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38129 | Film No.: 19953126